Premier Biomedical, Inc. (BIEI)
Stock Price: $0.0027 USD
-0.0003 (-10.00%)
Updated Mar 4, 2021 4:00 PM EST - End of day
| Market Cap | 2.50M |
| Revenue (ttm) | 14,281 |
| Net Income (ttm) | -374,470 |
| Shares Out | 52.40M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 4 |
| Last Price | $0.0027 |
| Previous Close | $0.0030 |
| Change ($) | -0.0003 |
| Change (%) | -10.00% |
| Day's Open | 0.0026 |
| Day's Range | 0.0025 - 0.0035 |
| Day's Volume | 22,608,853 |
| 52-Week Range | 0.0002 - 0.0084 |
News
There are no news available yet.
About BIEI
Premier Biomedical, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule,... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 2010 |
| CEO William Hartman | Country United States |
| Stock Exchange OTCMKTS | Ticker Symbol BIEI |
Financial Performance
In 2019, BIEI's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.